Friday 6 November 2026 Export RCEL’s income statement to Excel — free account

Avita Medical Inc.

RCEL Healthcare Medical Devices

Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024.

Revenue: +53.1%
EPS: +56.9%
Free cash flow: +86.7%
Total debt: +7.13%

Quarter to September 2026, against a year earlier

16.61 0.93 +5.93%

Follow RCEL

Alert me

Market cap: $389.5M
P/E: 0.0×
Fwd P/E: −16.0×
Dividend yield: —
F-score: 3/9
Altman Z: −11.21
Beneish M: −4.09
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	3	4
ROE Full definition →		799.72%	326.92%	211.55%	191.59%
ROA Full definition →		(71.40%)	(74.88%)	(81.36%)	(65.36%)
ROIC Full definition →		(334.18%)	(288.05%)	(306.20%)	0.00%
Return on Tangible Assets Full definition →		261.83%	169.09%	131.98%	(301.13%)
Average Days of Receivables Full definition →		46.31	49.87	47.62	44.58
Free Cash Flow per Share Full definition →		(1.18)	(1.06)	(0.82)	(0.65)
Free Cash Flow Full definition →		(32.83)	(32.40)	(25.25)	(19.91)
Capital Expenditures Full definition →		(1.64)	(1.44)	(1.02)	(0.20)
Other line items
Cash ROIC Full definition →		(73.76%)	(87.01%)	(84.28%)	(79.85%)
Accounts Receivable Turnover Full definition →		6.86	6.60	7.13	8.75
Accounts Payable Turnover Full definition →		1.68	1.70	2.04	2.31
Inventory Turnover Full definition →		1.80	1.86	2.18	2.48
Average Days of Payables Full definition →		255.59	195.44	168.06	118.23
Days of Inventory on Hand Full definition →		197.59	165.58	138.33	117.37
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		29.10%	27.90%	26.64%	24.91%
Selling, General and Administrative Expense of Revenue Full definition →		112.43%	108.07%	101.48%	91.34%
Share Based Compensation of Revenue Full definition →		13.29%	10.96%	9.57%	7.24%
Interest Coverage Full definition →		(8.71)	(7.73)	(6.97)	(5.42)
Operating CF/Net income Full definition →		0.64	0.68	0.56	0.55
Depreciation/Fixed assets Full definition →		0.27	0.30	0.33	0.34
Capex/Depreciation Full definition →		(0.70)	(0.59)	(0.41)	(0.08)
Revenue per Share Full definition →		2.57	2.37	2.46	2.74
Operating CF per Share Full definition →		(1.12)	(1.01)	(0.79)	(0.64)
Capex per Share Full definition →		(0.06)	(0.05)	(0.03)	(0.01)
Capex to Sales Full definition →		0.02	0.02	0.01	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly